Invision, a leading equity investment company, has acquisted a majority stake in Reofin Invest and indirectly Careanesth, including, without limitation, with regards to the acquisition financing provided by a syndicate of banks led by Luzerner Kantonalbank and the re-investment by the majority seller. The transaction was completed on 30 November 2022.
Invision is an investment company focusing on succession solutions and growth financing for medium-sized companies in German-speaking countries. The investment in Careanesth was the first transaction of the INVISION VII fund launched in early July 2022.
Since its founding in 1999, Careanesth has become the leading staffing agency for the placement of nursing professionals in the Swiss healthcare sector. The company has the technologies to address the shortage of skilled workers, but also to promote work-life balance.
Niederer Kraft Frey has advised Invision on the acquisition. The NKF team was led by partners Manuel Werder (corporate/m&a, pictured left), Thomas Graf (tax, pictured centre) and Adrian Koller (m&a/finance, pictured right), working with associate Binderiya Gan-Ayush (corporate/m&a), senior associate Morgan Boëffard (tax), counsel Janine Reudt-Demont (life sciences), partner Nicolas Birkhäuser and junior associate Yannik Bleiker (both antitrust/competition), associates Daniela Lötscher (employment), Jamie Lee Mancini (real estate) and junior associates Carlotta Ulmer (m&a/finance) and Marco Sidler (corporate/m&a).